FAP and heart failure: Recently, promising data has been published on the development of anti-FAP CAR-T cells to treat cardiac fibrosis, demonstrating that effective elimination of FAP-positive cells from the injury site in a mouse model of heart failure improved cardiac compliance (67, 68).